World EPA Congress 2022
Life sciences organizations, especially emerging Biotech companies offering solutions in rare diseases, increasingly struggle with determining and communicating the optimal market value of innovations.
Indegene will be at the World EPA Congress at Amsterdam in March this year, and talking about the impact of regulations and EU and UK environmental changes on PRMA in the innovative medicine and orphan drug space.
You can also meet our experts at Booth #10.
Our experts at booth #10
Indegene
Indegene
Indegene
What will be discussed?
Likely impact of EU4 & UK environmental changes on orphan PRMA
Potential impact of PRMA changes on innovative medicines
Proven solutions to identify and capture commercial value of assets
Our Sessions
Podium Session on "How much trouble ahead in orphan PRMA? Likely impact of EU4 & UK environmental changes", by Jack Mycka, VP, PRMA & Emerging Biotech Commercialization @Indegene, on 23rd March at 11:45 CET
Roundtable discussion - "Debating the potential impact of PRMA changes on innovative medicines in Europe", hosted by Jack Mycka, VP, PRMA & Emerging Biotech Commercialization @Indegene, on 23rd March at 13:55 CET
About the event
World EPA Congress 2022
March 22-24
Beurs Van Berlage, Amsterdam
World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, multiple streams and over 1000 attendees from pharma, biotech and Payers/HTA's.
Indegene is proud to be a silver sponsor at the event!
